The report, from Reveleer and Mathematica, reveals fragmented and inconsistent execution threaten outcomes. GLENDALE, Calif., Aug. 19, 2025 /PRNewswire/ --...
New Analysis from Consumer Edge's Hydrus Medical Claims Dataset Pinpoints Facility Types and Companies Facing Financial Risk Under Upcoming Medicaid...
Collaboration brings the Vineland-3 assessment directly into ATrack's clinical software, bringing greater accuracy and time savings to BCBA treatment planning....
Collaboration Extends Global Reach of High-Performance Genomic Sequencing on the UG 100™ Platform FREMONT, Calif. and HOUSTON, Aug. 19, 2025...
CARY, N.C., Aug. 19, 2025 /PRNewswire/ -- Millennia, a leader in patient revenue cycle and experience solutions for healthcare providers and...
Experienced executives John Groetelaars and Bill Jellison appointed to the Board of Directors Board forms new Growth and Operating committees to...
Offering empowers health plans to retain and grow ASO employer groups with AI-powered, omnichannel care navigation NEW YORK, Aug. 19,...
HIPAA-compliant cloud-based service provides diagnostic reports via the web with no installation requiredAI-powered trial service offered, highlighting potential for hospital-specific...
KENNESAW, GA / ACCESS Newswire / August 19, 2025 / The world of healthcare has changed drastically since the COVID-19...
ALEXANDRIA, VA / ACCESS Newswire / August 19, 2025 / The American Society of Consultant Pharmacists (ASCP) proudly announces the...
DENVER, COLORADO / ACCESS Newswire / August 19, 2025 / ForCast Orthopedics today announced the expansion of its Scientific Advisory...
Accelerated Round Completion Positions Company for New Drug Application (NDA) Submission and Commercial Launch Partnerships RALEIGH, NORTH CAROLINA / ACCESS...
MESA, ARIZONA / ACCESS Newswire / August 19, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today provided a corporate...
GRAND RAPIDS, MI / ACCESS Newswire / August 19, 2025 / SpendMend, a leading provider of solutions to optimize the...
As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral...
~Full Commercial Launch with Expanded Number of Instrument Sets and Field Support to Meet Growing Market Demand ~~ New SI...
Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4...
~ The Summit is the Premier Industry Event for Defining How New Product Planning Teams and Related Functions Make Informed,...
Black Book Research conducted this flash survey as both a service to the U.S. healthcare industry and a gesture of...
New agreement brings innovative shock wave, tPEMF therapy, monitoring, and bleeding control solutions to more than 2,200 member clinics nationwide...